These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29035551)

  • 41. Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
    Němeček J; Sychra P; Macháček M; Benková M; Karabanovich G; Konečná K; Kavková V; Stolaříková J; Hrabálek A; Vávrová K; Soukup O; Roh J; Klimešová V
    Eur J Med Chem; 2017 Apr; 130():419-432. PubMed ID: 28279848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nontoxic Metal-Cyclam Complexes, a New Class of Compounds with Potency against Drug-Resistant Mycobacterium tuberculosis.
    Yu M; Nagalingam G; Ellis S; Martinez E; Sintchenko V; Spain M; Rutledge PJ; Todd MH; Triccas JA
    J Med Chem; 2016 Jun; 59(12):5917-21. PubMed ID: 27214150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development.
    Beites T; O'Brien K; Tiwari D; Engelhart CA; Walters S; Andrews J; Yang HJ; Sutphen ML; Weiner DM; Dayao EK; Zimmerman M; Prideaux B; Desai PV; Masquelin T; Via LE; Dartois V; Boshoff HI; Barry CE; Ehrt S; Schnappinger D
    Nat Commun; 2019 Oct; 10(1):4970. PubMed ID: 31672993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
    van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF
    Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis.
    Giacobbo BC; Pissinate K; Rodrigues-Junior V; Villela AD; Grams ES; Abbadi BL; Subtil FT; Sperotto N; Trindade RV; Back DF; Campos MM; Basso LA; Machado P; Santos DS
    Eur J Med Chem; 2017 Jan; 126():491-501. PubMed ID: 27914363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secondary metabolites from Tetracera potatoria stem bark with anti-mycobacterial activity.
    Fomogne-Fodjo MC; Ndinteh DT; Olivier DK; Kempgens P; van Vuuren S; Krause RW
    J Ethnopharmacol; 2017 Jan; 195():238-245. PubMed ID: 27864111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homology modeling and molecular docking simulation of some novel imidazo[1,2-a]pyridine-3-carboxamide (IPA) series as inhibitors of Mycobacterium tuberculosis.
    Abdullahi M; Adeniji SE; Arthur DE; Haruna A
    J Genet Eng Biotechnol; 2021 Jan; 19(1):12. PubMed ID: 33474593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. QcrB in Mycobacterium tuberculosis: The new drug target of antitubercular agents.
    Bahuguna A; Rawat S; Rawat DS
    Med Res Rev; 2021 Jul; 41(4):2565-2581. PubMed ID: 33400275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase.
    Palencia A; Li X; Bu W; Choi W; Ding CZ; Easom EE; Feng L; Hernandez V; Houston P; Liu L; Meewan M; Mohan M; Rock FL; Sexton H; Zhang S; Zhou Y; Wan B; Wang Y; Franzblau SG; Woolhiser L; Gruppo V; Lenaerts AJ; O'Malley T; Parish T; Cooper CB; Waters MG; Ma Z; Ioerger TR; Sacchettini JC; Rullas J; Angulo-Barturen I; Pérez-Herrán E; Mendoza A; Barros D; Cusack S; Plattner JJ; Alley MR
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6271-80. PubMed ID: 27503647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimycobacterial activity of methanolic plant extract of Artemisia capillaris containing ursolic acid and hydroquinone against Mycobacterium tuberculosis.
    Jyoti MA; Nam KW; Jang WS; Kim YH; Kim SK; Lee BE; Song HY
    J Infect Chemother; 2016 Apr; 22(4):200-8. PubMed ID: 26867795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS
    Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. QSAR analysis of a set of benzimidazole derivatives based on their tuberculostatic activities.
    Geban O; Ertepinar H; Ozden S
    Pharmazie; 1996 Jan; 51(1):34-6. PubMed ID: 8999432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
    Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
    J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis.
    Korkegian A; O'Malley T; Xia Y; Zhou Y; Carter DS; Sunde B; Flint L; Thompson D; Ioerger TR; Sacchettini J; Alley MRK; Parish T
    Tuberculosis (Edinb); 2018 Jan; 108():96-98. PubMed ID: 29523334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.
    Gobis K; Foks H; Bojanowski K; Augustynowicz-Kopeć E; Napiórkowska A
    Bioorg Med Chem; 2012 Jan; 20(1):137-44. PubMed ID: 22153872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
    Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
    Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.